Y. Anouar, C. Desmoucelles, Y. L. Leprince, J. Breault, L. Gallo-payet et al., Identification of a novel secretogranin II-derived peptide (SgII (187-152)) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide, J Clin Endocrinol Metab, vol.83, pp.2944-2951, 1998.

M. Montero-hadjadje, G. Pelletier, Y. L. Guillemot, J. Li, S. Magoul et al., Biochemical characterization and immunocytochemical localization of EM66, a novel peptide derived from secretogranin II, in the rat pituitary and adrenal glands, J Histochem Cytochem, vol.51, pp.1083-1095, 2003.
URL : https://hal.archives-ouvertes.fr/hal-01706425

L. Yon, J. Guillemot, M. Montero-hadjadje, L. Grumolato, J. Leprince et al., Identification of the secretogranin II-derived peptide EM66 in pheochromocytomas as a potential marker for discriminating benign versus malignant tumors, J Clin Endocrinol Metab, vol.88, pp.2579-2585, 2003.
URL : https://hal.archives-ouvertes.fr/hal-01706414

M. Boutahricht, J. Guillemot, M. Montero-hadjadje, Y. Barakat, E. Ouezzani et al., Immunohistochemical distribution of the secretogranin II-derived peptide EM66 in the rat hypothalamus: A comparative study with jerboa, Neuroscience Lett, vol.414, pp.268-272, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01706443

M. Montero-hadjadje, S. Vaingankar, S. Elias, H. Tostivint, S. K. Mahata et al., Chromogranins A and B and secretogranin II: evolutionary and functional aspects, Acta Physiol. (Oxf ), vol.192, pp.309-324, 2008.
URL : https://hal.archives-ouvertes.fr/hal-02334366

M. Boutahricht, J. Guillemot, M. Montero-hadjadje, S. Bellafqih, E. Ouezzani et al., Biochemical characterisation and immunohistochemical localization of the secretogranin II-derived peptide EM66 in the hypothalamus of the jerboa (Jaculus orientalis): modulation by food deprivation, J Neuroendocrinol, vol.17, pp.372-378, 2005.

M. S. Harbuz, S. A. Nicholson, B. Gillham, and S. L. Lightman, Stress responsiveness of hypothalamic corticotropin-releasing factor and pituitary pro-opiomelanocortin mRNAs following high-dose glucocorticoid treatment and withdrawal in the rat, J Endocrinol, vol.127, pp.407-415, 1990.

J. P. Herman, D. Adams, and C. Prewitt, Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm, Neuroendocrinology, vol.61, pp.180-190, 1995.

K. Karalis, L. J. Muglia, D. Bae, H. Hilderbrand, and J. A. Majzoub, CRH and the immune system, J Neuroimmunol, vol.72, pp.131-136, 1997.

S. Makino, M. A. Smith, and P. W. Gold, Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels, Endocrinology, vol.136, pp.3299-3309, 1995.

C. Juaneda, P. Lafon-dubourg, P. Ciofi, A. Sarrieau, T. Wenger et al., CCK mRNA expression in neuroendocrine CRH neurons is increased in rats subjected to an immune challenge, Brain Res, vol.901, pp.277-280, 2001.

Y. Barakat, J. R. Pape, M. Boutahricht, A. El-ouezzani-s,-alaoui, M. Chaigniau et al., Immunocytochemical detection of CCK and CRH neuropeptides in the hypothalamic paraventricular nucleus of the jerboa (Jaculus orientalis): modulation by immobilization stress, J Neuroendocrinol, vol.18, pp.767-775, 2006.

S. Rivest, S. Lacroix, L. Vallieres, S. Nadeau, J. Zhang et al., How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli, Proc Soc Exp Biol Med, vol.223, pp.22-38, 2000.

R. Sapolsky, C. Rivier, G. Yamamoto, P. Plotsky, and W. Vale, Interleukin-1 stimulates the secretion of hypothalamic corticotropinreleasing factor, Science, vol.238, pp.522-524, 1987.

F. Crestani, F. Seguy, and R. Dantzer, Behavioural effects of preferentially injected interleukin-1: role of prostaglandins, Brain Res, vol.542, pp.330-335, 1991.

M. S. Harbuz, A. Stephanou, N. Sarlis, and S. L. Lightman, The effects of recombinant human interleukin (IL)-1?, IL-1? or IL-6 on hypothalamo-pituitary-adrenal axis activation, J Endocrinol, vol.133, pp.349-355, 1992.

A. Ericsson, K. J. Kovacs, and P. E. Sawchenko, A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons, J Neurosci, vol.14, pp.897-913, 1994.

F. Tilders, R. H. Derijk, A. Dam, K. Schotanus, and J. Persoons, Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals, Psychoneuroendocrinology, vol.19, pp.209-232, 1994.

S. Rivest and S. Lacroix, Influence of cytokines on neuroendocrine functions during immune response. Mechanisms involved and neuronal pathways, Ann Endocrinol, vol.56, pp.159-167, 1995.

G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, p.21, 1986.

S. Shu, G. Ju, and L. Fan, The glucose-oxidase DAB-nickel method in peroxydase histochemistry of the nervous system, Neurosci Lett, vol.85, pp.169-171, 1988.

O. Paulmyer-lacroix, V. Guillaume, G. Anglade, M. Grino, and C. Oliver, Regulation of corticotropic function in stressful situations, Ann Endocrinol, vol.56, pp.245-251, 1995.

J. P. Herman and W. E. Cullinan, Neurocircuitry of stress: central control of hypothalamo-pituitary-adrenocortical axis, Trends Neurosci, vol.20, pp.78-84, 1997.

S. Hayley and H. Anisman, Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: neurochemical and molecular substrates, Curr Pharm Des, vol.11, pp.947-962, 2005.

H. Anisman, M. O. Poulter, R. Gandhi, Z. Merali, and S. Hayley, Interferon-? effects are exaggerated when administered on a psychosocial stressor backdrop: cytokine, corticosterone and brain monoamine variations, J Neuroimmunol, vol.186, pp.45-53, 2007.

D. C. De-goeij, R. Kvetnansky, M. H. Whitnall, D. Jezova, F. Berkenbosch et al., Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats, Neuroendocrinology, vol.53, pp.150-159, 1991.

D. De-goeij, J. D. Tilders, and F. , Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus, Brain Res, vol.577, pp.165-168, 1992.

Z. Pirnik and A. Kiss, Fos expression variances in mouse hypothalamus upon physical and osmotic stimuli: co-staining with vasopressin, oxytocin, and tyrosine hydroxylase, Brain Res Bull, vol.5, pp.423-431, 2005.

K. Elmquist, T. E. Scammell, and C. B. Saper, Mechanisms of CNS response to systemic immune challenge: the febrile response, Trends Neurosci, vol.20, pp.565-570, 1997.

R. P. Gaykema, L. E. Goehler, M. K. Hansen, S. F. Maier, and L. R. Watkins, Subdiaphragmatic vagotomy blocks interleukin-1beta-induced fever but does not reduce IL-1beta levels in the circulation, Auton Neurosci, vol.85, pp.72-77, 2000.

L. R. Watkins, S. F. Maier, and L. E. Goehler, Cytokine-to-brain communication: a review & analysis of alternative mechanisms, Life Sci, vol.57, pp.1011-1026, 1995.

R. M. Bluthe, B. Michaud, K. W. Kelley, and R. Dantzer, Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally, Neuroreport, vol.7, pp.1485-1488, 1996.

R. Brown, Z. Li, C. Y. Vriend, R. Nirula, L. Janz et al., Suppression of splenic macrophage interleukin-1 secretion following intracerebroventricular injection of interleukin-1?: evidence for pituitary-adrenal and sympathetic control, Cell Immunol, vol.132, pp.84-93, 1991.

A. B. Cragnolini, M. Perello, H. B. Schiöth, and T. N. Scimonelli, ?-MSH and ?-MSH inhibit IL-1? induced activation of the hypothalamic-pituitary-adrenal axis through central melanocortin receptors, Regul Pept, vol.122, pp.185-190, 2004.